C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.435 AUD
3.99%
Market Closed
Updated:
Jun 1, 2024
Cyclopharm Ltd
Other Equity
|
Cyclopharm Ltd
Other Equity Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Other Equity
-AU$629.3k
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Other Equity
AU$65.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Other Equity
AU$8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
37%
|
|
|
Cochlear Ltd
ASX:COH
|
Other Equity
-AU$45m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Other Equity?
Other Equity
-629.3k
AUD
-629.3k
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Other Equity amounts to -629.3k AUD.
What is Cyclopharm Ltd's Other Equity growth rate?
Other Equity CAGR 10Y
-2%
-2%
Over the last year, the Other Equity growth was 40%. The average annual Other Equity growth rates for Cyclopharm Ltd have been 3% over the past three years , -3% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
